Research Strategies for Assessing Adverse Events Associated withVaccines:: A Workshop Summary
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Robert Chen, Chief of Vaccine Safety, National Immunization Program,Centers for Disease Control and Prevention
Mary Lou Clements, Professor and Director, Center for ImmunizationResearch, Johns Hopkins University
Elias Durry, Medical Epidemiologist, National Immunization Program,Centers for Disease Control and Prevention
Kathryn Edwards, Professor, Department of Pediatrics, VanderbiltUniversity
Susan Ellenberg, Director, Biostatistics and Epidemiology, Centerfor Biologics Evaluation and Research, U.S. Food and Drug Administration
Gerald Fenichel, Professor of Neurology and Pediatrics, Chairmanof the Department of Neurology, Vanderbilt University
Reinhard Fescharek, Drug Surveillance, Behringwerke AG
James Froeschle, Director of Clinical Research, Connaught Laboratories,Inc.
John Glasser, Epidemiologist, Vaccine Safety Activity, National ImmunizationProgram, Centers for Disease Control and Prevention
Karen Goldenthal, Acting Director, Division of Vaccines and RelatedProducts Applications, Center for Biologics Evaluation and Research,U.S. Food and Drug Administration
Steven Gordon, Ogden BioServices Corporation
Marie Griffin, Associate Professor, Department of Preventive Medicine,Vanderbilt University Medical Center
Penina Haber, Public Health Analyst, National Immunization Program,Centers for Disease Control and Prevention
Jill Hackell, Director, Clinical Research and Medical Affairs, BiologicalsClinical Research, Lederle Laboratories
Neal Halsey, Professor, Department of International Health, JohnsHopkins University School of Hygiene and Public Health
Carolyn Hardegree, Director, Vaccines Research and Review, Centerfor Biologics Evaluation and Research, U.S. Food and Drug Administration
William Jordan, Science Advisor, National Vaccine Program Office
Richard Kapit, Medical Officer, Biostatistics and Epidemiology, Centerfor Biologics Evaluation and Research, U.S. Food and Drug Administration
David Karzon, Professor of Pediatrics and Microbiology and Immunology,Vanderbilt University
Roland Levandowski, Acting Director, Division of Viral Products,Center for Biologics Evaluation and Research, Food and Drug Administration
Elizabeth Loupi, Drug Safety Monitor, Pharmacovigilance Department,Pasteur Mérieux Connaught Company
Marie Mann, Medical Officer, National Vaccine Injury CompensationProgram
Edgar Marcuse, Director, Ambulatory Care Services, Children's Hospital and Medical Center, Seattle
Sandy Mintz, Director, Parents Concerned about the Safety of Vaccines
J. Anthony Morris, Chairman, The Bell of Atri, Inc.